RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tanmoy Mondal to Neoplasms

Back to Details
This is a "connection" page, showing publications Tanmoy Mondal has written about Neoplasms.
Tanmoy Mondal
Connection Strength
0.264
Neoplasms
  1. Shivange G, Mondal T, Lyerly E, Bhatnagar S, Landen CN, Reddy S, Kim J, Doan B, Riddle P, Tushir-Singh J. A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors. Cell Rep. 2021 11 02; 37(5):109953.
    View in: PubMed
    Score: 0.099
  2. Shivange G, Mondal T, Lyerly E, Gatesman J, Tushir-Singh J. Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody. J Vis Exp. 2020 05 16; (159).
    View in: PubMed
    Score: 0.089
  3. Ali MM, Akhade VS, Kosalai ST, Subhash S, Statello L, Meryet-Figuiere M, Abrahamsson J, Mondal T, Kanduri C. PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers. Nat Commun. 2018 02 28; 9(1):883.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support